Q32 Bio (QTTB) Cash from Operations Growth (1y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 60.84% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 85.14% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -15.72% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 74.39% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 3.23% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 158.60% |
| 10 | Q32 Bio | 162.94 Mn | 112.19 Mn | - | 49.18% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 49.18% |
| Dec 31, 2025 | 45.92% |
| Sep 30, 2025 | 78.33% |
| Jun 30, 2025 | 52.05% |
| Mar 31, 2025 | 14.22% |
| Dec 31, 2024 | -6.65% |
| Sep 30, 2024 | -222.77% |
| Jun 30, 2024 | -95.43% |
| Mar 31, 2024 | -16.45% |
| Dec 31, 2023 | 60.61% |
| Sep 30, 2023 | 163.78% |
| Jun 30, 2023 | 63.15% |
| Mar 31, 2023 | 59.28% |
| Dec 31, 2022 | 10.62% |
| Sep 30, 2022 | 1.79% |
| Jun 30, 2022 | -27.93% |
| Mar 31, 2022 | -2.89% |
| Dec 31, 2021 | -162.06% |
| Sep 30, 2021 | 12.12% |
| Jun 30, 2021 | 13.85% |
| Mar 31, 2021 | -15.39% |
| Dec 31, 2020 | 55.90% |
| Sep 30, 2020 | -13.35% |
| Jun 30, 2020 | -29.15% |
| Mar 31, 2020 | -44.63% |
| Dec 31, 2019 | -225.94% |
| Sep 30, 2019 | -86.12% |
| Jun 30, 2019 | -122.32% |
| Mar 31, 2019 | -61.82% |
| Dec 31, 2018 | -136.64% |
| Sep 30, 2018 | -151.28% |
| Jun 30, 2018 | -74.20% |
| Mar 31, 2018 | -144.08% |